Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiac Imaging and Diagnostics, Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors, and Atrial Fibrillation Management and Outcomes.
Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis.
Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
Relative Predictive Value of Circulating Immune Markers in US Adults Without Cardiovascular Disease: Implications for Risk Reclassification
Myocardial perfusion artifacts in left bundle branch block: A diagnostic challenge.
SPECT-derived absolute myocardial perfusion measures: A step in the right direction.
Marijuana Use in Patients With Cardiovascular Disease
Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week.
Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.
Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)
Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial).
Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension
Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.
Effect of Immunomodulation on Cardiac Remodelling and Outcomes in Heart Failure: A Quantitative Synthesis of the Literature
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply.
Cardiac Function and Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)
Leucocyte Count Predicts Cardiovascular Risk in Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT Americas
Reduced Left Atrial Emptying Fraction and Chymase Activation in Pathophysiology of Primary Mitral Regurgitation.
Reduced Left Atrial Emptying Fraction and Chymase Activation in Pathophysiology of Primary Mitral Regurgitation
Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature.
Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas.
Complete versus culprit-vessel only revascularization in STEMI: An updated meta-analysis of randomized control trials.
FDG-PET/CT diagnosis of aortitis and pseudoaneurysms.
Using antimatter to uncover what matters: metformin effects on myocardial efficiency in heart failure.
Cases from a busy nuclear cardiology laboratory.
Measurement of blood flow in myocardial layers: A step toward comprehensive physiological evaluation.
Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT
Effect of a Community Health Worker-Based Approach to Integrated Cardiovascular Risk Factor Control in India: A Cluster Randomized Controlled Trial